D-dopaminergic receptor and 5-HT serotoninergic receptor antagonists having antiemetic profile | ||
Egyptian Pharmaceutical Journal | ||
Volume 12, Issue 1, June 2013, Pages 1-10 PDF (960.78 K) | ||
DOI: 10.7123/01.EPJ.0000428875.20180.de | ||
Authors | ||
Mohamed N. Aboul-Enein; Aida A. EL-Azzouny; Yousreya A. Maklad; Mohamed I. Attia; Mohamed Abd EL-Hamid Ismail; Walaa H.A. Abd EL-Hamid | ||
Abstract | ||
Metoclopramide is the prototype of the orthopramide family and is used clinically as a stimulant of upper gastrointestinal motility and as an antiemetic. Its antiemetic potential is attributed mainly to the antagonist activity at D-dopaminergic receptors in the chemoreceptor trigger zone of the central nervous system. Besides, ondansetron was the first selective 5-HT serotoninergic receptor antagonist used in clinics as an antiemetic. Herein, the antiemetic profile of different chemical classes of D-dopaminergic receptor and 5-HT serotoninergic receptor antagonists will be discussed, which may be helpful in the development of potent antiemetic agents. | ||
Keywords | ||
antagonists; Antiemetic; D-dopaminergic receptor; 5-HT serotoninergic receptor | ||
Statistics Article View: 49 PDF Download: 67 |